Cargando…
Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer
PURPOSE: Prostate cancer (PCa) patients often have dendritic cell (DC) function defects, but the mechanism is not clear. The aim of this study was to detect the effect of vascular endothelial growth factor (VEGF) in mature DCs. PATIENTS AND METHODS: In this study, we chose 30 PCa patients, 10 prosta...
Autores principales: | Bai, Wen-kun, Zhang, Wei, Hu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846303/ https://www.ncbi.nlm.nih.gov/pubmed/29563805 http://dx.doi.org/10.2147/OTT.S161302 |
Ejemplares similares
-
Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
por: Pratheeshkumar, Poyil, et al.
Publicado: (2012) -
Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling
por: Hu, Zu-Quan, et al.
Publicado: (2016) -
Low-frequency ultrasound-induced VEGF suppression and synergy with dendritic cell-mediated anti-tumor immunity in murine prostate cancer cells in vitro
por: Zhang, Wei, et al.
Publicado: (2017) -
The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton
por: Roberts, Emma, et al.
Publicado: (2013) -
Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells
por: WANG, HAIYAN, et al.
Publicado: (2015)